Repligen replacing Hi-Tech Pharmacal in S&P 600

|About: Repligen Corporation (RGEN)|By:, SA News Editor

Repligen (RGEN) will take Hi-Tech Pharmacal's (HITK) spot in the S&P SmallCap 600 following Thursday's close.

RGEN +2.6% AH